Back

Is myocardial infarction a surrogate endpoint for all-cause mortality? A trial-level meta-analysis of 144 randomized controlled trials enrolling 1.2 million patients from 1972-2020

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Congress committee e-posters choice in CAD/ACS/ACC Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Kevin O'Fee

Washington University School of Medicine, St Louis (United States of America)

28 More presentations in this session

Presentation thumbnail
Post-discharge major bleeding, myocardial infarction and mortality risk after coronary artery bypass grafting: A nationwide cohort study from the SWEDEHEART registry
Doctor E. Bjoerklund (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
Trends in cardiovascular mortality of cancer patients in the US over two decades 1999-2019
Doctor O. Kobo (Hadera, IL)
Abstract Slides
Presentation thumbnail
Underuse of reperfusiontherapy in STEMI with cardiogenic shock. Results of the EORP ACVC EAPCI STEMI registry of the ESC.
Professor U. Zeymer (Ludwigshafen, DE)
Abstract Slides
Presentation thumbnail
The effect of immediate coronary angiography after cardiac arrest without ST-segment elevation on left ventricular function. A sub-study of the COACT randomised trial
Doctor J. Lemkes (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Comparison of risk prediction models in infarct-related cardiogenic shock
Doctor A. Freund (Leipzig, DE)
Abstract Slides

Access the full session

Session thumbnail
Congress committee e-posters choice in CAD/ACS/ACC

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources